Evaluation of Pharmacodynamic Effects of IT-pIL12-EP in Patients With TNBC
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: ER-Negative PR-Negative HER2-Negative Breast Cancer
Interventions: BIOLOGICAL: IT-pIL12-EP
Sponsor: OncoSec Medical Incorporated